Advancing Enrollment and Reducing Drug Costs Act

Bill Number

H.R. 2340

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-03-25: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Last Updated

2025-04-22T16:04:49Z

AI-Generated Summary

Purpose

The "Advancing Enrollment and Reducing Drug Costs Act" (H.R. 2340) aims to simplify access to prescription drug coverage for certain low-income individuals transitioning from Medicaid to Medicare. It does this by automatically qualifying specific Medicaid beneficiaries for financial subsidies under Medicare Part D, which helps cover premiums and out-of-pocket costs for prescription drugs, thereby reducing barriers to enrollment and lowering drug expenses.

Key Provisions

• Automatic Qualification for Subsidies: Amends Section 1860D-14(a)(3)(B)(v) of the Social Security Act to add a new eligibility category for Medicare Part D low-income subsidies (also known as "Extra Help").
• Targets individuals who are eligible for Medicare Part D but do not qualify under existing low-income subsidy rules.
• Applies to those enrolled in Medicaid (under a state plan or waiver) as of the day before turning 65, specifically under clauses (i)(VIII) or (ii)(XX) of Section 1902(a)(10)(A)—these cover certain low-income groups like pregnant women, children, or disabled individuals.
• Requires household income below 200% of the federal poverty level (a measure of economic need based on family size and location).
• Provides subsidy eligibility for a "limited period of time," with details to be determined by the Secretary of Health and Human Services.
• Effective Date: Changes apply to Medicare Part D plan years starting on or after January 1, 2027.

Significant Changes to Existing Law

• Expansion of Eligibility: Previously, low-income subsidy eligibility under Medicare Part D required individuals to apply separately and meet specific income and resource tests. This bill introduces automatic qualification for a targeted group of Medicaid enrollees nearing Medicare age, bypassing the application process for them.
• Targeted Focus: Limits the change to those already in Medicaid under narrow categories and with income under 200% of poverty, rather than broadening subsidies universally. It does not alter core Medicaid or Medicare structures but streamlines the transition between programs.

Potential Impacts

• On Citizens: Low-income individuals (especially those aging into Medicare) gain easier access to affordable prescription drugs, potentially reducing financial burdens and improving health outcomes by encouraging consistent medication use. This could prevent gaps in coverage during the shift from Medicaid to Medicare.
• On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) will need to implement systems for automatic enrollment and define the "limited period" of eligibility, which may involve administrative updates and data sharing between Medicaid and Medicare programs. States administering Medicaid could see reduced enrollment hurdles but potential shifts in federal funding for dual-eligible individuals (those qualifying for both programs).
• On International Relations: No direct impacts, as the bill focuses on domestic U.S. health programs.
• Broader Effects: Could lower overall healthcare costs for vulnerable populations by minimizing uninsured drug expenses, though it may increase federal spending on subsidies (estimated impacts would depend on uptake and the defined eligibility period).

Main Stakeholders Affected

• Low-Income Beneficiaries: Primarily adults under 65 enrolled in specific Medicaid categories who will turn 65 and qualify for Medicare, with incomes below 200% of poverty—often including disabled individuals, caregivers, or those with chronic conditions.
• Federal Government: CMS and the Department of Health and Human Services, responsible for overseeing Medicare Part D and implementing the changes.
• State Governments: Medicaid programs, which must coordinate with federal systems to identify and transition eligible enrollees.
• Healthcare Providers and Insurers: Medicare Part D plan sponsors (e.g., private insurers offering drug plans) may see increased enrollment, affecting their administrative and reimbursement processes.
• Advocacy Groups: Organizations supporting seniors, low-income families, and dual-eligible individuals, who may benefit from reduced coverage gaps.

Notable Legal, Constitutional, or Political Implications

• Legal Implications: Strengthens coordination between Medicaid (Title XIX) and Medicare (Title XVIII) under the Social Security Act, promoting efficiency without requiring new rulemaking beyond the Secretary's specification of the eligibility period. It aligns with existing low-income protections but could face challenges if the "limited period" is seen as too vague, potentially needing clarification through regulations.
• Constitutional Implications: None significant; the bill operates within Congress's authority to regulate interstate commerce and social welfare programs, avoiding issues like equal protection or federalism concerns.
• Political Implications: Represents a bipartisan effort (introduced by Representatives Pappas and Tonko) to address healthcare access for vulnerable groups, potentially appealing to voters concerned with drug affordability. It could influence debates on Medicare sustainability and Medicaid expansion, especially amid ongoing discussions about federal health spending post-Inflation Reduction Act reforms. Referred to key committees (Energy and Commerce, Ways and Means), indicating scrutiny on fiscal and health policy grounds.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Pappas, Chris [D-NH-1]

Cosponsors (1)

Rep. Tonko, Paul [D-NY-20]

Recent Actions

• 2025-03-25: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-03-25: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-03-25: Introduced in House
• 2025-03-25: Introduced in House

Bill Versions

• Advancing Enrollment and Reducing Drug Costs Act — issued 2025-03-25 — PDF (3 pages)